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by other substructures. The potential clinical benefits still 
need to be demonstrated in expanded cohorts, with 
prolonged life-long follow-up. 
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Purpose or Objective: This study aims to investigate how 
much fractionation, and the different delivery dynamics of 
higher dose-per-fraction deliveries, can influence the impact 
of interplay effects for PBS-based lung tumour treatments. 
 
Material and Methods: For two example lung tumour cases (I 
and II), three-field 3D plans were calculated on a patient 
specific range-adapted ITV (rITV) using a spot spacing of 4mm 
orthogonal to the beam directions. 4D dose calculations were 
performed, simulating three different fractionation 
treatments with schemes of (A)2.5Gyx35fx, (B)5Gyx10fx and 
(C)13.5Gyx3fx, based on machine and delivery parameters of 
the Varian ProBeam system (lateral scanning speed of 5/20 
mm/ms and energy switching time of 700 ms with layer-wise 
optimized dose rates). 1x- to 10x- layered and volumetric 
rescanning was simulated to mitigate residual motion effects. 
The final dose distributions for fractioned treatments were 
obtained by superposition and normalization of the 4D dose 
distributions of each field and each fraction with random 
starting phases sampled from 4DCT (10 different phases with 
100 random starts). We used homogeneity index (HI:D5-D95) 
in the CTV to quantify the resultant 4D dose distributions 
within the target, while for the normal lung (both lungs 
minus CTV), V20, mean lung dose (MLD) and D2 were 
compared. 
 
Results: For single fraction only delivery (shown by error bars 
with hollow markers in figure a), the normalized HIs are 
similar for the different fraction doses for both patients, with 
HI being typically 14/15% higher than the static for case I and 
II respectively. For the full treatments (solid markers), the 
normalized HIs of plans under scheme A and B are equal or 
better than for the static plan, with only ±1.2% variations as 
a function of starting phase. In addition, whereas for scheme 
C, HI is 2.5±2.6/4.8±2.3% (Case I/II) higher than the static 
case, this also reaches comparable homogeneity as the static 
case once combined with moderate rescanning (<5x). 
Variability is also reduced to within 1%, independent of the 
rescanning technique used. Concerning treatment time, for 
single fractions, nearly no difference can be seen among the 
different schemes when no rescanning is applied, due to the 
layer-wise optimized dose rate used by the ProBeam system. 
For 5x LS or VS, treatment time is increased by 100% and 37% 
respectively for scheme C in comparison to scheme A, 
although the absolute treatment time for LS is always less 
than half that of VS for all schemes. For the whole 
treatment, more than 75% reduction of time cost can be 
obtained once fractionation scheme (C) is used. 
 
 
 
Conclusion: For PBS-based lung tumour proton therapy, 
fractionation can lead to an improved target homogeneity, 
and variability as a function of starting phase is only obvious 
when large fraction doses are used and can be reduced with 
moderate (<5x) rescanning is applied. 
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Purpose or Objective: One of the major limitations of IOERT 
is the lack of a postoperative image based treatment 
planning, in order to optimize the radiotherapy procedure. 
The aim of this study is to develop and introduce a 
postoperative image based treatment planning system for 
breast cancer IOERT. 
 
Material and Methods; to obtain a postoperative image 
based treatment planning software, it is necessary to have a 
postoperative image which includes the anatomical 
modifications of the tumor bed after the surgery. To this 
end, a C-arm fluoroscopy system (Zeihm Vision-8000) was 
employed to obtain a series of 2D images which include the 
tumor bed together with the IORT applicator and protection 
disk.In addition to the postoperative images, it is mandatory 
to have the complete isodose distributions for different 
combinations of applicator size/energy. To obtain this data, 
Monte Carlo simulation was employed. The LIAC IORT 
accelerator was simulated by MCNPX code and then, isodose 
distributions were extracted using mesh tally inside a water 
phantom. To develop a graphical treatment planning 
software, a graphical user interface (GUI) was prepared by an 
in house program written with MATLAB. At first, the 
postoperative image is imported to the program. Then, the 
corresponding isodose distribution file is loaded to the 
program. Then, the user will specify the applicator edge and 
program registers the isodose curves to the postoperative 
image. In order to evaluate the performance accuracy of the 
implemented postoperative image based treatment plans and 
delivered dose to the patient, in vivo dosimetry was used. To 
this end, the delivered dose to the surface of tumor bed was 
measured by Gafchromic EBT2 film. 
 
Results: The result of intraopertaive imaging and 
corresponding treatment planning is shown in Fig. 1. 
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As it can be seen, the developed treatment planning system 
is able to clearly show the variations of isodose levels at the 
site of tumor bed. Therefore, treatment team can precisely 
determine the interested isodose level for the dose 
prescription.The results of in vivo dosimetry at the surface of 
tumor bed showed there is no meaningful difference between 
the measured and expected dose at the surface of tumor bed 
(P-value=0.92). 
 
Conclusion: The feasibility of intraoperative imaging and 
development of a postoperative image based treatment 
planning system during breast cancer IOERT was investigated 
in this study. The results of in vivo dosimetry confirm the 
validity of the developed treatment planning system for 
clinical applications. 
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Purpose or Objective: To compare the differences between 
average doses cumulated in the marrow of iliac plates (PBM), 
obtained for five different radiotherapy strategies of cervical 
and endometrial cancer. 
 
Material and Methods: A total of 150 treatment plans were 
calculated retrospectively for 30 patients with cervical and 
endometrial cancer.  
For each case, 3 different dose delivery techniques were 
used. It were respectively: (i) 4-field, X15MV, 3DCRT; (ii) 7-
field, X6MV, IMRT; and (iii) 2-arc, X6MV, VMAT. Two 
strategies were used during preparation of the IMRT and 
VMAT plans. The first take into account (+) PBM during 
optimization of the dose distribution and the second, do not 
take it into account (-).  
All plans were normalized on the median dose in PTV. The 
same calculation algorithm (AAA) was used for calculation of 
the dose for each of plan. The total dose was 50.4 Gy (1.8 Gy 
in 28 fractions).  
Average doses cumulated in PTV, PBM, bladder, rectum, 
bowels and femoral heads obtained from the evaluated plans 
were compared. In addition, the doses accumulated in PBM 
were analyzed in the light of the volume of PTV and/or PBM.  
The statistical analysis were performed by Friedman ANOVA 
with Nemenyi's procedures used as post-hoc tests. In order to 
find the relationship between doses in PBM and volume of 
PTV and/or PBM, the Spearman correlation was used. All 
tests were performed on the significance level equal to 0.05. 
 
Results: Table 1 shows the result of the comparison of the 
average dose in the light of the generated plans. 
 
 
 
The average dose in PTV for evaluated plans was similar. The 
worst doses in organs at risk were obtained for 3DCRT. Using 
the PBM during optimization of IMRT and VMAT reduces the 
average dose in PBM without increasing the doses in bladder, 
rectum and bowels. Differences between doses in PBM for 
IMRT and VMAT plans, where PBM was used during 
optimization, were not statistically significant. The 
correlation between mean dose in PBM and the volume ratio 
of PBM and PTV was found for each technique (Figure 1). 
 
 
 
Conclusion: Using the PBM during optimization of the IMRT 
and VMAT plans effectively reduces the dose in PBM without 
increasing the dose in bladder, rectum and bowels. The 
doses, obtained in PBM for IMRT and VMAT are not 
statistically different. Decreasing the PBM volume in relation 
to PTV increases the mean dose in PBM. 
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Purpose or Objective: The introduction of lung stereotactic 
body radiation therapy (SBRT) requires images that allow a 
more precise delineation of the tumor and its movement. The 
free breathing CT does not contain information on the 
variable electron density over time. The objective of this 
study is to analyze the CT mode that provides the best 
estimation of the tumor movement and the most appropriate 
image set for the calculation of the dose distribution image. 
 
Material and Methods: 10 patients were retrospectively 
investigated. For each patient, a retrospective 4DCT was 
acquired using a Brilliance 16-slice scanner. From the 4DCT 
study, 10 respiratory phases, an average CT and a maximum 
intensity projection (MIP) were reconstructed. The gross 
tumor volumes (GTV) were delineated in each image set of 
the 4DCT using a MIM® 6.4 software. Three internal target 
volumes (ITV) were obtained, one from the union of GTVs 
delineated in each phase, another from the average CT and 
the last from the MIP reconstruction. Special care was taken 
with the window level selection when contouring. The size of 
the three ITVs was compared. The planning target volume 
